Post-Traumatic Stress Disorder - 331-201-00071 (Otsuka)
Clinical trial to examine the efficacy and safety of brexpriprazole combined with sertraline as treatment for adults with posttraumatic stress disorder.
Qualified participants include:
- Adults aged 18 to 65 years old
- Have been diagnosed with posttraumatic stress disorder
- Onset of symptoms for a minimum of 6 months prior to screening
Those that qualify will:
- Receive study drug and study-related care with a board-certified psychiatrist and other clinical staff at no cost.
- Receive reimbursement for study participation and costs.
Contact Clinical Trials at 860.545.7476 or via email clinical.trials@hhchealth.org